Source: Virtual Congress 2020 – Quantitative imaging in diffuse lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Eaden (Sheffield, United Kingdom), H. Chan (Sheffield, United Kingdom), N. Weatherley (Sheffield, United Kingdom), S. Bianchi (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom). Regional hyperpolarised 129-xenon diffusion-weighted MRI in patients with IPF. 4333

Member's Comments

No comment yet.

Related content which might interest you: Hyperpolarised 129-xenon diffusion-weighted MRI in interstitial lung disease Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019 Year: 2019 Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial Source: Eur Respir J 2009; 34: 1311-1321 Year: 2009 Comparison of 1H MRI and 3He MRI ventilation images in patients with cystic fibrosis and patients with lung cancer Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities Year: 2018 Comparison of in-vivo lung morphometry models from multiple b-value diffusion-weighted MRI in healthy controls, IPF and COPD patients Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses Year: 2017 Hyperpolarised 129Xe magnetic resonance imaging to monitor treatment response in children with cystic fibrosis Source: Eur Respir J, 53 (5) 1802188; 10.1183/13993003.02188-2018 Year: 2019 Spirometer-controlled cine magnetic resonance imaging used to diagnose tracheobronchomalacia in paediatric patients Source: Eur Respir J 2014; 43: 115-124 Year: 2004 Gas-exchange and ventilation imaging of COPD in comparison to a healthy cohort using hyperpolarized Xenon-129 MRI Source: International Congress 2019 – Imaging of airway diseases Year: 2019 Apparent diffusion coefficient (ADC) of hyperpolarized ³He magnetic resonance imaging (MRI) in patients with emphysema and healthy volunteers Source: Eur Respir J 2004; 24: Suppl. 48, 235s Year: 2004 MDCT and MRI DWI early signs of COPD Source: Annual Congress 2012 - Standard of care, incidential findings, image acquisition Year: 2012 Quantitative multivolume proton-magnetic resonance imaging in patients with cystic fibrosis lung disease: comparison with clinical indicators Source: Eur Respir J, 53 (5) 1702020; 10.1183/13993003.02020-2017 Year: 2019 The value of magnetic resonance imaging (MRI) with gadolinium as a noninvasive diagnostic method in cardiac sarcoidosis Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis Year: 2008 Fourier-decomposition of free-breathing pulmonary proton MRI in asthma Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 Diagnostic accuracy of unenhanced and gadolinium-enhanced magnetic resonance imaging for acute pulmonary embolism diagnosis: Results of the "IRM-EP" study Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011 Benchmarking inhaled nanoparticle measurements of airspace dimension with hyperpolarised 129Xe diffusion-weighted MRI Source: Virtual Congress 2020 – Imaging-based phenotyping in pulmonary disease Year: 2020 Comparison of the thoracic CT-based computational model with hyperpolarized Xenon-129 MRI and SPECT images to assess pulmonary ventilation in COPD patients Source: International Congress 2019 – Imaging: new insights that pulmonologists should be aware of Year: 2019 Whole-body magnetic resonance imaging in extrathoracic sarcoidosis Source: Eur Respir J 2014; 43: 1812-1815 Year: 2014 MRI of delayed-ventilation perfusion matching in COPD Source: Annual Congress 2012 - Functional imaging of the lung parenchyma, tumours and circulation Year: 2012 Longitudinal monitoring of lung microstructure with HP gas diffusion-weighted MRI in mild cystic fibrosis children Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers Year: 2017 Functional lung MRI in COPD: Comparative assessment of T1 mapping, oxygen-enhanced T1 mapping and perfusion MRI at 1.5 Tesla Source: International Congress 2014 – The MRI modality becomes clinically mature: lung MRI Year: 2014